Pain experienced by many patients with advanced cancer is often not well controlled and community pharmacists are potentially well placed to provide support. The study objective was to explore the views and experiences of patients with advanced cancer about community pharmacies, their services and attitudes towards having a community pharmacist pain medicines consultation. Purposive sampling of GP clinical information systems was used to recruit patients with advanced cancer, living in the community and receiving opioid analgesics in one area of England, UK between January 2015 and July 2016. Thirteen patients had a semi-structured interview which was audio-recorded and transcribed verbatim. Data were analysed deductively and inductively using Framework analysis and incorporating new themes as they emerged. The framework comprised Pain management, Experiences and expectations, Access to care and Communication. All patients reported using one regular community pharmacy citing convenience, service and staff friendliness as influential factors. The idea of a community pharmacy medicines consultation was acceptable to most patients. The idea of telephone consultations was positively received but electronic media such as Skype was not feasible or acceptable for most. Patients perceived a hierarchy of health professionals with specialist palliative care nurses at the top (due to their combined knowledge of their condition and medicines) followed by GPs then pharmacists. Patients receiving specialist palliative care described pain that was better controlled than those who were not. They thought medicines consultations with a pharmacist could be useful for patients before referral for palliative care. There is a need for pain medicines support for patients with advanced cancer, and unmet need appears greater for those not under the care of specialist services.
| INTRODUC TI ON
Three quarters of people who die from cancer will have experienced pain and it is the most common reason patients with cancer contact out-of-hours services (Adam, Bond, & Murchie, 2015; IMPACCT, 2016) . Pain is less well controlled among patients living in community settings compared with those in the hospice or hospital (VOICES National Survey of Bereaved People, 2014). Cancer pain is complex and often changes rapidly with disease progression (Hackett, Godfrey, & Bennett, 2016) . Many patients increasingly want to spend their last days and weeks in their own homes which has created an increasing need for community-based patients to be better supported to ensure they receive pain management (Adam et al., 2015; Bennett, Bagnall, & Closs, 2009; . Community pharmacies are situated in every locality and are often open up to 100 hours a week giving patients free and easy access to a healthcare professional without the need to wait for an appointment; however, they are widely thought to be an underused resource as many patients often do not realise they can be a source of medicines information (Bennie, Dunlop Corcoran, Trundle, Mackay, & Akram, 2013) .
In the British National Health Service (NHS) community, pharmacists are funded to provide patient-centred medicines optimisation services that could support patients with less well-controlled cancer pain. However, the sparse research in this area found that these services are rarely carried out with this patient group (Savage, Blenkinsopp, Closs, & Bennett, 2013) . Medicine optimisation services currently available in community pharmacies in England and Wales include the Medicines Use Review (MUR) and the New Medicine Service (NMS). MURs are consultations with patients where all patient medication is discussed and explained and often issues around concordance, compliance and supply are addressed. NMS concentrates on newly prescribed medicines and involves two consultations (usually by telephone) to ensure medicines are started and no side effects or problems ensue. There is RCT evidence that NMS detects adverse effects from medicines, positively influences prescribing and improves treatment adherence (NMS Evaluation 2014) . A recent review of the limited evidence relating to MUR concluded that "in line with their intended purpose, patient knowledge and self-reported adherence may improve following MURs" (Wright, 2016, p37) .
Current policy allows community pharmacists to carry out MURs with patients living with cancer pain, but the NMS service can only be provided for patients being newly prescribed medicines for certain conditions; cancer and pain are not included (PSNC 2017) . MURs are intended to be provided face-to-face when a patient is in the pharmacy unless permission is requested on an individual patient basis from NHS England (PSNC 2017) . Patients with advanced cancer may not come into pharmacies and their medicines are often collected by relatives or supplied by delivery drivers (Savage et al., 2013) .
Where medicines optimisation interventions have been carried out with patients suffering from cancer pain, there is evidence of benefit; systematic reviews of educational interventions for cancer pain (by any healthcare professional) found a reduction in average and worst pain intensity. Pharmacist educational interventions for patients with chronic pain showed a reduction in pain intensity, adverse events and an improvement in satisfaction with treatment (Bennett, Bagnall, et al., 2009 . There are no systematic reviews of pharmacist interventions for cancer pain as very few studies have ever been carried out.
Community pharmacists are the health professional with whom patients with cancer pain have most frequent contact alongside palliative care nurses with 75% of patients having contact within a 2-week period ).
Community pharmacists can currently access only limited information about their patients and they do not routinely know which of their patients have cancer. A previous study with community pharmacists found that little communication occurs between them and other healthcare professionals about the care of patients with cancer with pharmacists rarely finding out the diagnosis of the patients whose medicines they were dispensing (Savage et al., 2013) . The introduction of Summary Care Record (SCR) access for community pharmacies in 2016 has improved information sharing but not all prescribing is recorded and diagnoses are rarely included (NHS Digital, 2017) .
Research on community pharmacists' views about providing services for patients with cancer indicates a perceived lack of knowledge and need for training (O'Connor, Hewitt, & Tuffin, 2013; Savage et al., 2013) . However, little research has investigated how patients with advanced cancer use community pharmacies and attitudes towards having medicines consultations.
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EDWARDS Et Al.
• To investigate the acceptability of community pharmacy medicines consultation services and find out what patients with cancer pain might need from such a service.
| ME THOD
A qualitative method of semi-structured interviews was chosen as the study topic was complex and so far unexplored (Bowling, 1997) .
Following a review of the literature, the interview schedule was developed in line with the study aims. Topics included current interaction with pharmacy, services and experiences of them and views on potential future services (see Table S1 ). Interviews were semistructured in design to ensure focus on the research aims while allowing in-depth discussion on points of interest. The interview was piloted with two patients and minor amendments to language were made.
This research is part of a wider programme which is a multidisciplinary body of work involving three Universities. Ethical permission was granted from the NHS Ethics committee.
| Sampling and recruitment
Purposive sampling was carried out to ensure focus on the views of patients experiencing pain from advanced cancer. The assumption was made that patients would have some involvement/contact with community pharmacies through dispensing of prescribed medicines.
The inclusion criteria for patients were:
• Aged over 16 years Communities 2015). The researcher was not allowed direct access to the practice clinical information system so practice pharmacists carried out searches. Letters of invitation were sent to the practice manager, with telephone follow-up by researcher 1 and meetings were arranged to discuss the research where the practice wished to do so. Twenty-one surgeries were invited to take part and 16 agreed to do so.
Each practice pharmacist carried out a pre-designed search of the practice clinical information system to identify patients who had any cancer code attached to their record. The practice pharmacist then individually searched the patients' record to check whether their cancer code was current and they had advanced cancer.
For those patients identified as being potentially eligible to take part, a task was sent to their GP to ask whether they were suitable for inclusion in the study, i.e. they had capacity to provide informed consent and had not deteriorated since the search. A letter of invitation, participation information sheet and consent form were then posted from the surgery including details of the research pharmacist, why the research was being carried out and what would happen.
Completed consent forms were returned to the research pharmacist at the university. Reminders were not sent as the health of this patient group is likely to change rapidly leading to changes in eligibility.
The target sample size was 15 patients or when data saturation was reached (Fusch & Lawrence, 2015; Malterud, Siersma, & Guassora, 2016) .
| Data collection
The interview guide was developed using the aims of the study and is available as a supplement to this paper (Table S1 ). Participants were given the choice as to where they would like the interview to be carried out and were asked if they would like to have a family member or carer present with them during the interview. The research pharmacist carried out the majority of interviews with a second researcher helping when the research pharmacist was unavailable. Although the research pharmacist had limited experience of interviewing, they had extensive consultation experience and were supported by a highly experienced research lead and wider group.
Following each interview the researcher carrying out the interview wrote reflective field notes to support analysis. Patients were recruited and interviewed until two interviews after no new themes emerged, at which point it was concluded that data saturation had occurred (Fusch & Lawrence, 2015) .
| Data analysis
Interviews were audio-recorded and transcribed verbatim before being analysed using thematic Framework analysis by the research pharmacist (Ritchie & Lewis, 2003) . This method was chosen as it allows analysis across participants leading to the development of meaningful themes while still allowing the context of each individual taking part (Gale, Heath, Cameron, Rashid, & Redwood, 2013; Smith & Firth, 2011) . A combined approach of inductive and deductive analysis was used. We were interested in pharmacy use in patients | 511
with cancer pain; however, we wanted the qualitative interview data to inform our themes and allow unexpected findings to be explored (Gale et al., 2013) .
Interview transcripts were read and re-read by researcher 1 and researcher 2 to gain familiarity alongside field notes from both researchers (researchers 1 and 3) following which a framework was developed. The framework was then applied to the data. Data were then sorted into similar concepts before being summarised.
Descriptive categories were then allocated and refined by researcher 1, 2 and 4 several times until the authors were satisfied with the themes and sub-themes assigned.
In the Results section which follows the verbatim quotations from participants are coded using a site-code (S) and a patient number code (P). C corresponds to a carer or family member who was involved in the interview.
| FINDING S
In total 121 patients were identified from searches of GP clinical information systems and subsequent individual review of notes. GPs assessed 73 patients were suitable for invitation and were sent an invitation pack.
Thirteen patients returned a completed consent form and agreed to be interviewed (from 7 of the 16 surgeries) and all requested the interview to take place in their own home. Patients were aged between 40 and 89 years old; 10 were male and 3 were female and they lived in areas with deprivation scores of between 2 and 10 (Open Data Communities 2015). Interviews lasted between 27 and 51 min and none were repeated. Saturation of themes was apparent after the eleventh interview. Table 1 summarises key characteristics of the patients in the study. Three patients were interviewed in the presence of family members who also contributed to the discussion.
Interview findings
Ten sub-themes were identified from the analysis (between two and three per theme) (Figure 1 ).
| Pain Management (Box 1)

| Adequacy of pain control
Pain levels and reported adequacy of pain control varied considerably among the patients. Those receiving specialist palliative care appeared to be more comfortable with how to manage their pain and who to turn to for help. They explained how their medication could be changed in a timely manner in response to changing needs.
The patients who were not receiving specialist palliative care services seemed to have pain that was less well controlled.
| Knowledge of medicines
Some patients were very knowledgeable about their pain medicines, while others appeared to know little and voiced a need for more information that could give them practical advice on how to get the best from their medicines.
Some patients did not realise that they had insufficient knowledge to be able to use their medicines to manage their pain and were unsure of which medicine was being used for which symptom. One patient
did not know what their MST (morphine sulphate prolonged release) tablets were for. It seems unlikely that this patient would be able to adequately control their fluctuating pain levels with regular and top-up medication without a better understanding of their purpose.
| Experimentation with medicines
Experimentation through reducing the dosage taken was sometimes in response to concerns over addiction and tolerance (where a patient believed that the medicine might become less effective if taken over a period of time). Some patients were uncomfortable with their "tablet burden" and wanted to reduce medicine taking to the lowest possible level that would still control symptoms.
Occasionally professionals were reported to have been dismissive of patients' fears and anxieties, leading to patients not seeking further advice from them. One patient had tried to voice their concerns about taking too much pain medication to their healthcare professional and went on to reduce their medicine taking on their own. 
| Experiences and Expectations (Box 2)
| Community pharmacies
All patients interviewed reported using one regular community pharmacy (one, also additionally used a hospital pharmacy regularly at outpatient visits for specially prescribed treatment). Pharmacy location was important, sometimes through convenience and the pharmacy's proximity to the patient's GP surgery. Some patients talked about a preference for independent pharmacies rather than chains.
One patient had limited mobility and spoke about having to leave plenty of time to walk to the bus stop before catching the bus to the GP surgery. Using the pharmacy next to the surgery made their life much easier.
Service was also an important factor for patients in choosing which community pharmacy to use and several patients had changed pharmacies after repeated perceptions of poor service.
In contrast some patients described having "good relationships"
with their community pharmacy team. Examples of how these relationships manifested themselves were where pharmacy staff knew the patient's name or were reported to have gone "above and beyond" what might be expected from them.
Patients felt that occasional problems with pharmacies such as mistakes or stock issues could sometimes be forgiven if they perceived the staff to be friendly and trying their best.
The positive experiences were not without exception and lack of relationship rather than a negative relationship was expressed.
Patients seemed to value more than just the basic level of service from their community pharmacy and wanted to be treated with friendliness by staff who knew them. This attribute positively influences the continuity of pharmacy use.
| Hierarchy of professionals
Patients perceived a hierarchy of professionals with whom they came into contact in primary care depending on who was involved and the stage in their cancer journey they were at (e.g. diagnosis, treatment, non-treatment and palliative care). Those patients who were under the care of specialist palliative care services would, without exception, always refer any problem to them.
One patient believed the specialist palliative care nurse had more expertise about cancer than GPs as well as dealing with cancer pain on a day-to-day basis.
The GP was viewed as second in line to go to for advice, or first in line if the patient did not have access to palliative care advice.
The community pharmacist was mentioned by one patient as being an option for advice.
One patient who reported positive experience of clinical interventions questioned the capability of community pharmacists to provide advice as they may have less knowledge about medicines than doctors.
| Support for medicines taking
Patients were introduced to the idea of a community pharmacy medicines consultation to support medicines taking. Although seven patients were aware of community pharmacy services, only three had experience of them and none of these had been since their cancer diagnosis.
The need for support was felt more by those were not receiving palliative care services and therefore did not have direct access to advice from palliative care professionals.
Patients were positive about the prospect of receiving community pharmacy services to help with their medicines use but many saw that as being the role of their GP.
The patients described how their medicines and doses had changed over time, making support after a medicine is prescribedimportant and useful.
| Access to Care (Box 3)
| Resilience and responsibility
Patients talked about problems they experienced with managing supplies of their medicines and strategies they used either at the time or developed following an incident to prevent it happening again.
Early ordering of prescriptions to allow the pharmacy time to order items not in stock was a common way to prevent a patient from running out of medicines. 
That's it yeah … Is that a painkiller? (S1P1)
Experimentation
I'm always experimenting actually … I don't know if that's a good thing or not. (S13P1) [The doctor said] we can see that … there isn't a right lot we can do about it, you know you just have to [take them]. (S8P1) B O X 2 Expectations and experiences
Community pharmacies
It's our local pharmacy because it's the nearest … and it's right next to the GP. So if the GP gives you a prescription … you just pop into the pharmacy next door. Its … the whole experience of supporting your local community … rather than a big chain. (S5P4) [The pharmacy] is directly opposite the doctors it's the easiest one … I get my prescription then I can just walk over and get it there. (S7P1)
[ 
Hierarchy
I don't see the doctor … I deal with the Macmillan Nurse … [they] visit me regularly erm I've no doubt I'll be seeing [them] next week, [they] just phone up and ask if it's ok to come along er, I just can't fault [them]. (S5P2) Before you were in touch with [the palliative care nurse], was there anyone else you'd speak to? Interviewer Straight to the doctor (640) (S10P1)
If I couldn't get into the doctor I'd ring the pharmacy. (S1P3) Because they can be very helpful can the pharmacists but they might not, I mean they aren't qualified doctors so they might just give you something thinking they were very helpful and you might take it and it might upset the cart … (S1P1)
Support for medicines taking
If I were offered [a community pharmacy consultation] then I wouldn't take it up because I prefer to speak to my doctor … who knows more about me than anyone else. (S5P3) Well [they] can't tell me about that, it's got to be my cancer specialist (nurse). (S2P1) I was thinking that this week, thinking I'd really like to just talk to someone and say is it OK to just do this and take that every day once a day without taking Lansoprazole or is that going to really affect my stomach, you know it's like I don't know the answer to that so there's lots of questions around it. (S13P1) I'm just still in a lot of pain. (S7P1) What do you do when that happens? Who do you talk to? Interviewer Erm, I just sort of struggle through. (S7P1) I think that's a good idea … and it would be good to review that occasionally. But I thought that would be done by the doctor who is, is treating you. (S5P4) It's quite a good idea … especially with the cancer medication and they do have a lot of side effects and sometimes even if they discuss the side effects … when you're experiencing the side effects, you do wonder [should it really be] as bad as this? (S13P2)
When a patient was seen by a doctor outside of usual working hours, this posed particular challenges. One patient explained about a time they had been given a prescription for emergency painkillers at 2 a.m. and there was no community pharmacy open where it could be dispensed.
The prescribing doctor was not able to suggest a solution, and it was only afterwards that the patient thought of a different way that they might have been able to get the medicine.
| Alternative methods to access/contact healthcare professionals
Patients were familiar with contacting healthcare professionals by telephone and many described ordering medication by phone or ringing community pharmacies with queries. Most patients would accept medicines consultations with their pharmacist by telephone, and some thought that this method would be easier due to mobility problems or trying to fit in multiple health appointments around other commitments.
Some patients preferred face-to-face contact with a healthcare professional and one raised potential communication difficulties which may occur with telephone conversations.
Patients were also asked how they felt about the possibility of using electronic devices (computers, smartphones, etc.) to access healthcare professionals using tools such as Skype or Facetime.
Four patients responded positively; however, most of the patients voiced their lack of access to computers or computer literacy as reasons for not wanting access in this form (Table 2 ).
| Communication (Box 4)
| Conflict and duplication
The patients in this study were receiving care from many healthcare professionals and described how they sometimes received conflicting messages.
Where a patient thought they had access to sufficient advice about pain medicines, the involvement of an extra person such as the community pharmacist was seen as having potential to introduce further conflicting advice.
| Patient-centred communication
When talking about communication between healthcare professionals, one patient was surprised to learn their community pharmacist did not have access to their records as their perception was that they were a "safety-net" where all their medicines from different sources were collated and checked. There was an assumption that communication between the different professionals and across care transitions occurred more than it did in reality.
| D ISCUSS I ON
This study explored patients' perspectives about community pharmacy services in the context of pain management in advanced cancer. Our findings confirm those of other studies that there is unmet need for additional medicines support for some patients (and their carers) during pain management in palliative care in cancer (Adam et al., 2015; Bennett, Bagnall, et al., 2009; Closs et al., 2009; Latter, Hopkinson, Richardson, Hughes, & Edwards, 2016) . Similar numbers of patients in this study were receiving and not receiving specialist palliative care services therefore allowing insight into the needs, experiences and perceptions of both groups.
To our knowledge this study is the first to explore continuity of pharmacy use and the only to explore use by patients with advanced
B O X 3 Access to care
Resilience and responsibility with access to their medical history. General practitioners were next followed by the community pharmacist. This is in line with findings from a previous knowledge-based study where nurses were found to know the most, followed by GPs and pharmacists with regard to pain assessment in palliative care (Furstenburg et al., 1998) . Several other studies have also demonstrated a need for further pharmacist training in palliative care knowledge and issues surrounding difficult conversations (Borgsteede, Rhodius, Pasman, Onwuteaka-Philipsen, & Rurup, 2011; Hussainy et al., 2006; O'Connor et al., 2013; Savage et al., 2013) . Where pharmacists have been trained to provide community palliative care services in Scotland, healthcare professionals saw them as their "first port of call" for information about palliative medicines (Akram, Dunlop Corcoran, MacRobbie, Harrington, & Bennie, 2017) .
Although this is a small study, the findings indicate that patients who are not receiving specialist palliative care seem less able to gain optimal use from their pain medicines and have no timely access to advice in times of worsening symptoms or crisis. This is supported by the Voices survey where only 18% of patients in community settings were likely to describe their pain as being completely controlled compared with 38% in hospital and 68% in hospice environments (VOICES National Survey of Bereaved People, 2014). Referral to palliative care is known to happen relatively late in the journey of a terminal cancer patient and one-third of patients who die from cancer never receive specialist palliative care services (Ziegler et al., 2017) .
The idea of resilience of the patient to cope with problems has been found in other disease areas, not just palliative care (Fylan, Armitage, Naylor, & Blenkinsopp, 2017) . Of course, not all patients want to be referred to specialist palliative care or indeed, have the opportunity to be. Therefore, a need exists for medicines support either before that referral occurs or for patients who stay under the care of their GP.
Most patients found the idea of a community pharmacy medicines consultation acceptable whether face-to-face or by telephone.
Patients felt that this would be of most value early on in the cancer pain journey and before the involvement of specialist services.
Patients were generally uncomfortable with the idea of medicines Patients' need to experiment with their medication to try and achieve pain relief at the lowest possible dose was evident and this could be helped by educational interventions to either optimise the medicines they have already been prescribed, allay any fears or stigma surrounding the use of strong painkillers or to refer to prescribers for a dose change. This is backed up by previous research which found an improvement in pain scores for patients with cancer pain who received educational interventions (Bennett, Bagnall et al., 2009 ).
| S TRENG TH S AND LIMITATI ON S
We encountered challenges with recruitment mainly due to potential participants being too unwell to participate and therefore views of patients with very advanced disease are not included.
The study was conducted across a single UK city with a diverse socioeconomic population; however, we recognise the findings may not be transferable to other parts of the UK.
While the average age of participants was 64 years old and the majority were male, there is evidence that older patients do not experience cancer pain differently although there is evidence to suggest that there are gender differences in healthcare utilisation Wang, Hunt, Nazareth, Freemantle, & Peterson, 2013) .
The interviewer was a research pharmacist and their professional background was shared with the participants and potentially influencing the views expressed with a degree of participant eagerness to please and say the "right thing" and paint community pharmacy in a positive light (Jack, 2008) . Conversely the background of the researcher aided understanding of issues throughout the interviews and therefore they acted as an "embedded researcher"
(Vindola-Padros 2015). Reflexivity was practised by the researcher throughout.
At the beginning of the interview process, researchers were unaware of all important issues for the patients with regard access to equipment. This unfortunately led to a small amount of missing data for computer ownership. We feel that as this was the case with such a small number of participants, it does not devalue our findings.
Any qualitative study relies on the interpretation of the data and this may affect the reliability of the results. In the current study, this was mitigated by the involvement of other research team members in discussions about coding and during the write-up of results.
| IMPLI C ATI ON S OF THE S TUDY
Our findings have implications for practice, policy and research. The most effective use of a community pharmacy medicines consultation appears to be for patients who are not receiving specialist palliative care and the pharmacists need to be appropriately trained in both theory and consultation skills to provide such a service. The development of referral pathways to identify these patients is a necessary next step and a pathway from community pharmacy to palliative care could be usefully explored. Based on the findings of the study reported here, we have delivered NMS style consultations by telephone to patients with pain from advanced cancer and the results could inform future policy discussions. It is vital that any new service is designed with the needs of the patients in mind and is accessible for all who need it. Our findings show a need for medicines support for some patients with pain from advanced cancer and that they are receptive to a telephone-based consultation with a healthcare professional. Widening access to telephone medicines consultations could contribute to improving access to pain medicines support in advanced cancer.
| CON CLUS ION
